Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Free Cash Flow (2010 - 2026)

Vericel (VCEL) posted Free Cash Flow of $14.5 million for Q2 2026, down 3.08% sequentially from $14.9 million in Q1 2026, and up 17755.56% YoY from N/an in Q2 2025.

Analysis

Vericel (VCEL) Free Cash Flow (2010 - 2026) Analysis & Trends

Vericel has reported Free Cash Flow for 17 years, with the latest figure at $14.5 million in Q2 2026.

  • Quarterly Free Cash Flow rose 17755.56% year-over-year to $14.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $61.7 million (up 842.85% YoY) and the FY2025 annual result came in at $24.7 million, up 525.88% from the prior year.
  • Free Cash Flow fell to $14.5 million in Q2 2026 per VCEL's latest filing, from $14.9 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $19.5 million in Q3 2025 and troughed at -$9.2 million in Q3 2024.
  • A 5-year average of $4.1 million and a median of $2.5 million in 2022 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2024 and 2026: Free Cash Flow plunged 1637.5% in 2024, then soared 17755.56% in 2026.
  • Over 5 years, Free Cash Flow stood at $5.6 million in 2022, then tumbled by 59.96% to $2.3 million in 2023, then jumped by 275.61% to $8.5 million in 2024, then surged by 51.71% to $12.8 million in 2025, then rose by 12.75% to $14.5 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered $14.5 million, $14.9 million, and $12.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -563.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -389.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 437.80 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 292.04 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 477.44 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -95.09 Mn
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 14.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.46 Mn
Mar 31, 2026 14.92 Mn
Dec 31, 2025 12.83 Mn
Sep 30, 2025 19.45 Mn
Jun 30, 2025 81,000.00
Mar 31, 2025 -7.61 Mn
Dec 31, 2024 8.46 Mn
Sep 30, 2024 -9.23 Mn
Jun 30, 2024 1.77 Mn
Mar 31, 2024 -6.82 Mn
Dec 31, 2023 2.25 Mn
Sep 30, 2023 600,000.00
Jun 30, 2023 6.87 Mn
Mar 31, 2023 5.58 Mn
Dec 31, 2022 5.62 Mn
Sep 30, 2022 2.69 Mn
Jun 30, 2022 1.16 Mn
Mar 31, 2022 387,000.00
Dec 31, 2021 9.56 Mn
Sep 30, 2021 1.17 Mn